Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Total Assets

Latest as of March 2026: CN¥6.03 Billion CNY ≈ $881.78 Million USD

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) holds total assets worth CN¥6.03 Billion CNY (≈ $881.78 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Anhui Huaheng Biotechnology Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.

Anhui Huaheng Biotechnology Co. Ltd. A - Total Assets Trend (2012–2025)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Check cash flow quality index of Anhui Huaheng Biotechnology Co. Ltd. A to evaluate the quality of earnings relative to operating cash generation.

Anhui Huaheng Biotechnology Co. Ltd. A - Asset Composition Analysis

Current Asset Composition (December 2025)

Anhui Huaheng Biotechnology Co. Ltd. A's total assets of CN¥6.03 Billion consist of 25.4% current assets and 74.7% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	4.9%
Accounts Receivable	CN¥587.63 Million	10.2%
Inventory	CN¥532.13 Million	9.2%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥150.04 Million	2.6%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2012–2025)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Anhui Huaheng Biotechnology Co. Ltd. A market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Anhui Huaheng Biotechnology Co. Ltd. A's current assets represent 25.4% of total assets in 2025, a decrease from 65.6% in 2012.
Cash Position: Cash and equivalents constituted 4.9% of total assets in 2025, down from 22.1% in 2012.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2012.
Asset Diversification: The largest asset category is accounts receivable at 10.2% of total assets.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Total Assets

Key competitors of Anhui Huaheng Biotechnology Co. Ltd. A based on total assets are shown below.

Company	Country	Total Assets
argenx NV ADR NASDAQ:ARGX	USA	$8.68 Billion
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.98 Billion
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
Hebei Changshan Biochem Pharma SHE:300255	China	CN¥4.66 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Neuren Pharmaceuticals Ltd AU:NEU	Australia	AU$331.25 Million
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	China	CN¥6.82 Billion
Wuhan Hvsen Biotechnology Co Ltd SHE:300871	China	CN¥3.25 Billion

Anhui Huaheng Biotechnology Co. Ltd. A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.21	1.03	4.83
Quick Ratio	0.77	0.69	4.43
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥304.43 Million	CN¥40.62 Million	CN¥668.20 Million

Anhui Huaheng Biotechnology Co. Ltd. A - Advanced Valuation Insights

This section examines the relationship between Anhui Huaheng Biotechnology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.55
Latest Market Cap to Assets Ratio	0.13
Asset Growth Rate (YoY)	15.7%
Total Assets	CN¥5.77 Billion
Market Capitalization	$763.84 Million USD

Valuation Analysis

Below Book Valuation: The market values Anhui Huaheng Biotechnology Co. Ltd. A's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Anhui Huaheng Biotechnology Co. Ltd. A's assets grew by 15.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)

The table below shows the annual total assets of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥5.77 Billion ≈ $845.02 Million	+15.74%
2024-12-31	CN¥4.99 Billion ≈ $730.11 Million	+25.67%
2023-12-31	CN¥3.97 Billion ≈ $580.97 Million	+95.86%
2022-12-31	CN¥2.03 Billion ≈ $296.63 Million	+37.51%
2021-12-31	CN¥1.47 Billion ≈ $215.71 Million	+98.43%
2020-12-31	CN¥742.89 Million ≈ $108.71 Million	+32.40%
2019-12-31	CN¥561.09 Million ≈ $82.10 Million	+3.69%
2018-12-31	CN¥541.13 Million ≈ $79.18 Million	+31.32%
2017-12-31	CN¥412.06 Million ≈ $60.30 Million	+6.74%
2016-12-31	CN¥386.04 Million ≈ $56.49 Million	+33.49%
2015-12-31	CN¥289.20 Million ≈ $42.32 Million	+52.28%
2014-12-31	CN¥189.91 Million ≈ $27.79 Million	+2.66%
2013-12-31	CN¥184.98 Million ≈ $27.07 Million	+46.92%
2012-12-31	CN¥125.90 Million ≈ $18.42 Million	--

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology

Market Cap

$763.84 Million

CN¥5.22 Billion CNY

Market Cap Rank

#10274 Global

#2783 in China

Share Price

CN¥20.87

Change (1 day)

+0.87%

52-Week Range

CN¥20.48 - CN¥41.34

All Time High

CN¥85.44